3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate has been researched along with Idiopathic Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barry, F; Cheng, EM; Connor, KI; Ganz, DA; McNeese-Smith, DK; Mittman, BS; Siebens, HC; Vickrey, BG | 1 |
1 trial(s) available for 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Implementation fidelity of a nurse-led RCT-tested complex intervention, care coordination for health promotion and activities in Parkinson's disease (CHAPS) in meeting challenges in care management.
Topics: Cholic Acids; Health Promotion; Humans; Nurse's Role; Parkinson Disease; Quality of Health Care | 2022 |